HUP0105481A2 - Klaritromicint vagy származékait tartalmazó gyógyászati készítmények és eljárás előállításukra, valamint alkalmazásuk - Google Patents

Klaritromicint vagy származékait tartalmazó gyógyászati készítmények és eljárás előállításukra, valamint alkalmazásuk

Info

Publication number
HUP0105481A2
HUP0105481A2 HU0105481A HUP0105481A HUP0105481A2 HU P0105481 A2 HUP0105481 A2 HU P0105481A2 HU 0105481 A HU0105481 A HU 0105481A HU P0105481 A HUP0105481 A HU P0105481A HU P0105481 A2 HUP0105481 A2 HU P0105481A2
Authority
HU
Hungary
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
medicinal preparations
scope
Prior art date
Application number
HU0105481A
Other languages
English (en)
Inventor
Darja Fercej Temeljotov
Milojka Mohar
Marko Opresnik
Ljubomira Barbara Rebic
Mateja Salobir
Original Assignee
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. filed Critical Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D.
Publication of HUP0105481A2 publication Critical patent/HUP0105481A2/hu
Publication of HUP0105481A3 publication Critical patent/HUP0105481A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány szerinti gyógyászati készítmények napi egyszeri orálisbeadásra szolgálnak, amelyek klaritromicint vagy származékáttartalmazzák zsíros és hidrofil komponens elegye mellett. A találmánytárgyköréhez tartozik továbbá eljárás a fenti gyógyá- szatikészítmények előállítására, amelynek során a gyógyászati készítményalkotórészeit homogén állapot eléréséig keverik, szitálják ésoldószerek alkalmazása nélkül közvetlenül tablettákká sajtolják. Atalálmány tárgyköréhez tartozik ezenkívül a fenti gyógyászatikészítmények alkalmazása bakteriális fertőzések kezelésére ésmegelőzésére. Ó
HU0105481A 1999-02-19 2000-02-17 Pharmaceutical compositions containing clarithromycin and process for their preparation and their use HUP0105481A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI9900039A SI20150A (sl) 1999-02-19 1999-02-19 Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina

Publications (2)

Publication Number Publication Date
HUP0105481A2 true HUP0105481A2 (hu) 2002-05-29
HUP0105481A3 HUP0105481A3 (en) 2003-04-28

Family

ID=20432410

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0105481A HUP0105481A3 (en) 1999-02-19 2000-02-17 Pharmaceutical compositions containing clarithromycin and process for their preparation and their use

Country Status (21)

Country Link
EP (1) EP1150686B1 (hu)
AT (1) ATE286736T1 (hu)
AU (1) AU776912B2 (hu)
BG (1) BG65324B1 (hu)
CY (1) CY1107454T1 (hu)
CZ (1) CZ302781B6 (hu)
DE (1) DE60017361T2 (hu)
DK (1) DK1150686T3 (hu)
EE (1) EE05422B1 (hu)
ES (1) ES2235834T3 (hu)
HR (1) HRP20010684B1 (hu)
HU (1) HUP0105481A3 (hu)
PL (1) PL196665B1 (hu)
PT (1) PT1150686E (hu)
RS (1) RS50298B (hu)
RU (1) RU2237480C2 (hu)
SI (2) SI20150A (hu)
SK (1) SK287525B6 (hu)
TR (1) TR200102396T2 (hu)
UA (1) UA74778C2 (hu)
WO (1) WO2000048607A1 (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200000054A2 (tr) * 2000-01-05 2001-08-21 Sanovel İlaç San. Ve Ti̇c. Anoni̇m Şi̇rketi̇ Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları.
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
IN192748B (hu) * 2000-08-29 2004-05-15 Ranbaxy Lab Ltd
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6673369B2 (en) 2001-08-29 2004-01-06 Ranbaxy Laboratories Limited Controlled release formulation
CA2405918A1 (en) * 2001-10-01 2003-04-01 Ind-Swift Limited Controlled release macrolide pharmaceutical formulations
SE0103369D0 (sv) * 2001-10-09 2001-10-09 Astrazeneca Ab Pharmaceutical formulation
WO2003037304A1 (en) 2001-11-02 2003-05-08 Wockhardt Limited Controlled release compositions for macrolide antimicrobial agents
CN1652753A (zh) * 2002-04-03 2005-08-10 兰贝克赛实验室有限公司 具有改进的生物利用度的克拉霉素制剂
US20060083759A1 (en) * 2002-07-17 2006-04-20 Aleksander Resman Stabilization of the profile of release of active substances from a formulation
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
WO2004010970A1 (en) * 2002-07-29 2004-02-05 Alza Corporation Formulations and dosage forms for controlled delivery of topiramate
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
WO2005023221A1 (en) * 2003-09-05 2005-03-17 Ranbaxy Laboratories Limited Clarithromycin formulations having improved biovailability
US7943585B2 (en) * 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
MXPA06010805A (es) * 2004-03-24 2006-12-19 Lupin Ltd Formulacion de claritromicina de libracion prolongada.
EP2283824B1 (en) 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS60163823A (ja) * 1984-02-03 1985-08-26 Taisho Pharmaceut Co Ltd 経口投与製剤
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS63188621A (ja) * 1987-01-30 1988-08-04 Taisho Pharmaceut Co Ltd 矯味経口製剤
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
IL87219A0 (en) * 1987-08-07 1988-12-30 Abbott Lab Erythromycin formulations for oral administration
JP2553882B2 (ja) * 1987-08-08 1996-11-13 富士写真光機株式会社 走査結像光学系
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
DK0744941T3 (da) * 1994-02-16 2003-09-29 Abbott Lab Fremgangsmåde til fremstilling af findelte farmaceutiske formuleringer

Also Published As

Publication number Publication date
HUP0105481A3 (en) 2003-04-28
ATE286736T1 (de) 2005-01-15
EE200100433A (et) 2002-12-16
EP1150686A1 (en) 2001-11-07
ES2235834T3 (es) 2005-07-16
CZ302781B6 (cs) 2011-11-02
AU776912B2 (en) 2004-09-23
SI1150686T1 (en) 2005-06-30
HRP20010684A2 (en) 2002-10-31
EP1150686B1 (en) 2005-01-12
PL196665B1 (pl) 2008-01-31
BG65324B1 (bg) 2008-02-29
SI20150A (sl) 2000-08-31
AU2704900A (en) 2000-09-04
DE60017361T2 (de) 2005-12-22
RU2237480C2 (ru) 2004-10-10
PT1150686E (pt) 2005-05-31
DK1150686T3 (da) 2005-04-04
EE05422B1 (et) 2011-06-15
CZ20012964A3 (cs) 2002-01-16
UA74778C2 (en) 2006-02-15
YU59201A (sh) 2004-07-15
RS50298B (sr) 2009-09-08
DE60017361D1 (de) 2005-02-17
HRP20010684B1 (en) 2011-01-31
SK11972001A3 (sk) 2002-02-05
WO2000048607A1 (en) 2000-08-24
SK287525B6 (sk) 2011-01-04
CY1107454T1 (el) 2012-12-19
PL350419A1 (en) 2002-12-16
TR200102396T2 (tr) 2002-01-21
BG105914A (bg) 2002-05-31

Similar Documents

Publication Publication Date Title
HUP0105481A2 (hu) Klaritromicint vagy származékait tartalmazó gyógyászati készítmények és eljárás előállításukra, valamint alkalmazásuk
MXPA02003596A (es) Composiciones farmaceuticas novedosas de farmacos anti tubercular y procedimiento para su preparacion.
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
HUP0201877A2 (hu) Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
HUP0000299A1 (hu) Késleltetett hatóanyag-leadású gyógyszerkészítmények
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
MY118371A (en) Tetrahydrolipstatin containing compositions
MY111177A (en) Flavour-masked pharmaceutical compositions
PT1412384E (pt) Formulação estável de glp-1 modificado
MY115351A (en) Pharmaceutical formulations
GEP20053595B (en) Cyclopentanoindoles, Compositions Containing Such Compounds and Methods of Treatment
HUP0204110A3 (en) Amphiphilic prodrugs, process for preparation and use of pharmaceutical compositions containing them
IL142801A0 (en) Pharmaceutical compositions containing an adenosine analog
HUP0500558A2 (hu) Alacsony dózisú entecavir formuláció és eljárás előállítására
HUP0301349A2 (hu) IL-11-tartalmú készítmények
HUP0402154A2 (hu) Metformint és glibenklamidot tartalmazó gyógyászati készítmény II-es típusú diabetes mellitus kezelésére
HUP0401592A2 (hu) Modafinilvegyület és ciklodextrin keverékek, eljárás az előállításukra és ezeket tartalmazó készítmények
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
TW200503782A (en) New formulations and use thereof
HUP0105364A2 (hu) Spontán diszpergálódó N-benzoil sztaurosporint tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0104410A2 (hu) Ateroszklerózis megelőzésére és/vagy kezelésére szolgáló gyógyszerkészítmények
HUP0303454A2 (hu) 4-Ciano-trifluor-3-(4-fluor-fenil-szulfonil)-2-hidroxi-2-metil-propiono-m-toluididet és pvp-t tartalmazó szilárd gyógyászati készítmény
BR0312728A (pt) Formulação em tablete dispersìvel e processo para sua preparação
EP1057828A3 (en) Trovafloxacin oral suspensions

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished